期刊文献+

静脉注射胺碘酮转复快速心房颤动疗效的临床观察

下载PDF
导出
摘要 目的观察静脉注射胺碘酮转复快速心房颤动的治疗效果及其安全性。方法对90例快速心房颤动患者给予胺碘酮150mg加5%葡萄糖液10mL静脉注射,10min注射完毕,观察30min后未转复可重复应用,继以0.5~1mg/min维持静脉滴注24h,观察用药后2、6、12、24h转复率、心室率、不良反应。结果用药2h内转复率30.0%(27/90),6h内转复率55.6%(50/90),12h内转复率70.0%(63/90),24h内转复率82.2%(74/90),且用胺碘酮期间并未出现严重不良反应。结论静脉注射胺碘酮转复新发快速心房纤颤安全有效,尤其适用于合并器质性心脏病的患者。
作者 陈雷
出处 《中国医药指南》 2011年第24期288-289,共2页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献22

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2Goldschlager N, Epstein A E, Naccarlli G, et al. Practical guidelines for clinicians, Who treat patients with amiodarone[J]. Arch Intem Med,2000,160: 1 741.
  • 3Siddoway L A. Amiodarone: Guidelines for use and monitoring[J]. Am Fam physician,2003,68: 2 189.
  • 4Kodana I, Kamiyak, Toyama J.Callular electropharmacology of amiodarone[J].Carodiovascular Research,1997,35: 13.
  • 5Kamiya K, Cheng J,Kodama I,et al. Modulation of repolarizaing Potassium channels and Kv1.5 mRNA by long-term treatment with amiodarone[J]. Circulation,1995,92(S1):373.
  • 6Vitolo E, Tronci M, Larovere MT,et al. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation[J]. Acta Cardiol, 1981,36: 431.
  • 7Zehender M, Hohnloser S, Müller B,et al.Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation results of a comparative study and a 2-year follow up[J]. J A CC,1992,19: 1 054.
  • 8Kochiadakis GE, Igaumenidis NE, Marketou ME,et al. Low dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation[J]. Am J Cardiol,1998,81:995.
  • 9Khan IA. Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J,2004,25: 1 274.
  • 10Donovan KD, Power BM, Hockings BEF, et al. Intravenous flecaimide versus amiodarone for recent-onset atrial fibrillation[J]. Am J Cardiol,1995,75: 693.

共引文献447

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部